EMTRICITABINE+TENOFOVIR DISOPROXIL belongs to a group of antiretroviral medicines used to treat HIV infection. EMTRICITABINE+TENOFOVIR DISOPROXIL helps in decreasing the chance of developing AIDS (acquired immunodeficiency syndrome) and other HIV-related illness such as cancer or serious infections. EMTRICITABINE+TENOFOVIR DISOPROXIL also helps in reducing the risk of getting HIV-1 infection when used as a daily treatment along with practising safe sex.
EMTRICITABINE+TENOFOVIR DISOPROXIL is a combination of two drugs, namely: Emtricitabine and Tenofovir disoproxil. Emtricitabine is a nucleoside reverse transcriptase inhibitor, whereas Tenofovir disoproxil is a nucleotide reverse transcriptase inhibitor. EMTRICITABINE+TENOFOVIR DISOPROXIL works by interfering with the working of nucleotide and nucleoside reverse transcriptase enzymes which are necessary for the reproduction of the virus. Together, EMTRICITABINE+TENOFOVIR DISOPROXIL helps in treating HIV infection.
You are advised to take EMTRICITABINE+TENOFOVIR DISOPROXIL for as long as your doctor has prescribed it for you depending on your medical condition. In some cases, EMTRICITABINE+TENOFOVIR DISOPROXIL may cause certain common side-effects such as headache, dizziness, nausea, vomiting, diarrhoea, weakness, and rash. Most of these side-effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side-effects persistently.
Practise safe sex and take necessary precautions, as EMTRICITABINE+TENOFOVIR DISOPROXIL does not prevent the spread of HIV infection. Consult your doctor if you are pregnant or planning for pregnancy. Avoid breastfeeding while taking EMTRICITABINE+TENOFOVIR DISOPROXIL. EMTRICITABINE+TENOFOVIR DISOPROXIL may cause dizziness, so drive with caution. EMTRICITABINE+TENOFOVIR DISOPROXIL is not recommended for children below 12 years. Keep your doctor informed about your health condition and the medicines you are taking to prevent any side-effects/interactions.
HIV infection
EMTRICITABINE+TENOFOVIR DISOPROXIL belongs to a group of antiretroviral medicines used to treat HIV infection. EMTRICITABINE+TENOFOVIR DISOPROXIL helps in decreasing the chance of developing AIDS (acquired immunodeficiency syndrome) and other HIV-related illnesses such as cancer or serious infections. EMTRICITABINE+TENOFOVIR DISOPROXIL is a combination of two drugs, namely: Emtricitabine and Tenofovir disoproxil. Emtricitabine is a nucleoside reverse transcriptase inhibitor, whereas Tenofovir disoproxil is a nucleotide reverse transcriptase inhibitor. EMTRICITABINE+TENOFOVIR DISOPROXIL works by interfering with the working of nucleotide and nucleoside reverse transcriptase enzymes which are necessary for the reproduction of the virus. Together, EMTRICITABINE+TENOFOVIR DISOPROXIL helps in treating HIV infection. Taking EMTRICITABINE+TENOFOVIR DISOPROXIL along with practising safe sex and lifestyle changes may reduce the risk of getting or transmitting the HIV virus to others.
Do not take EMTRICITABINE+TENOFOVIR DISOPROXIL if you are allergic to any of its contents. Inform your doctor if you have a history of hepatitis B infection, kidney or liver problems or if you are older than 65 years. Regularly get blood and urine tests done while taking EMTRICITABINE+TENOFOVIR DISOPROXIL. Practise safe sex and take other necessary precautions as EMTRICITABINE+TENOFOVIR DISOPROXIL does not prevent the spread of HIV infection. Consult your doctor if you are pregnant or planning for pregnancy. Avoid breastfeeding while taking EMTRICITABINE+TENOFOVIR DISOPROXIL. EMTRICITABINE+TENOFOVIR DISOPROXIL may cause dizziness, so drive with caution. EMTRICITABINE+TENOFOVIR DISOPROXIL is not recommended for children below 12 years. Talk to your doctor immediately if you notice any signs or symptoms of infection or inflammation.
Drug-Drug Interactions: EMTRICITABINE+TENOFOVIR DISOPROXIL may interact with anti-HIV (ritonavir, darunavir), anti-fungal (amphotericin B), anti-viral (foscarnet, ganciclovir, cidofovir), antimicrobial (pentamidine), antibiotic (vancomycin), anti-cancer (interleukin-2).
Drug-Food Interactions: No interactions found/established.
Drug-Disease Interactions: No interactions found/established.
It is not known whether alcohol interacts with EMTRICITABINE+TENOFOVIR DISOPROXIL. Please consult your doctor.
Please consult your doctor if you are pregnant; your doctor will prescribe only if the benefits outweigh the risks.
Avoid breastfeeding while taking EMTRICITABINE+TENOFOVIR DISOPROXIL as it may pass into breastmilk.
EMTRICITABINE+TENOFOVIR DISOPROXIL may cause dizziness. So, drive or operate machinery only if you are alert.
Dose adjustment may be needed. Please consult your doctor before taking EMTRICITABINE+TENOFOVIR DISOPROXIL if you have a liver impairment or any concerns regarding this.
Dose adjustment may be needed. Please consult your doctor before taking EMTRICITABINE+TENOFOVIR DISOPROXIL if you have kidney impairment or any concerns regarding this.
EMTRICITABINE+TENOFOVIR DISOPROXIL is not recommended for children below 12years.
HIV infection: HIV (Human Immunodeficiency Virus) is a virus that attacks the immune system and destroys the white blood cells that help in fighting infection, making the individual susceptible to other infections or illnesses. People with HIV experience flu-like symptoms such as fever, chills, rash, night sweats, muscle aches, tiredness, and sore throat. These symptoms usually last for days to several weeks. HIV spreads through body fluids such as semen, vaginal fluid, and blood. If left untreated, this condition can lead to AIDS (Acquired Immunodeficiency Syndrome). It is a life-long condition, and there is no definite cure for it. However, it can be controlled by treating it with antiretroviral drugs.